Keyword: Intellectual Property (IP)

News

China’s chemical industry

13.12.2013 - In Move Toward Consumption-Led Economy, Specialty and High-End Chemical Segments Will Further ExpandA World Leader - The chemical industry in China is both a key driver and prime...

Plant Construction & Process Technology

Outsourcing Biopharmaceutical Manufacturing

12.11.2013 - Development On Trial - The number of biopharmaceutical projects in clinical trials and products is increasing, playing an important role in new treatments. Many of these projects...

Chemistry & Life Sciences

Intellectual Property Protection in China

24.07.2013 - Ideas In Jeopardy - For chemical companies doing business in China, few concerns are as ubiquitous as the risk of the theft or loss of intellectual property. Of all the forms of IP...

News

South Africa Seeks to Close Drug Patent Loophole

22.04.2013 - South Africa plans to overhaul its intellectual property laws to improve access to cheaper medicines by making it harder for pharmaceutical firms to register and roll-over patents...

News

Novartis Loses Landmark India Cancer Drug Patent Case

02.04.2013 - India's top court dismissed Swiss drugmaker Novartis's attempt to win patent protection for its cancer drug Glivec, a blow to Western pharmaceutical firms targeting India to drive...

News

U.S. Struggles with Pharmaceutical Goals in Asia Trade Talks

29.03.2013 - The United States is striving to find an appropriate balance in Asia-Pacific free trade talks between providing strong patent and data protections for U.S. drug manufacturers and...

News

Big Pharma in Nervous Wait for India Verdict on Glivec Patent

27.03.2013 - Global drugmakers, battered by recent intellectual property decisions in India, are girding for a landmark court ruling next week that could have broad consequences for their...

News

India Rules Against Bayer in Cancer Drug Patent Case

04.03.2013 - An Indian patent appeals board dismissed on Monday Bayer's petition against a government decision to allow a domestic company to sell cheap copycat versions of cancer drug Nexavar...